CORRELATION ANALYSIS OF GSTP1 GENE POLYMORPHISM WITH MORBIDITY OF PRIMARY METASTATIC COLORECTAL CANCER
Author:
Bazhora Yuri1, Chetverikov Sergii2, Onyshchenko Viacheslav1, Chetverikov Mykhailo2, Chetverikova-Ovchynnyk Valeriia2
Affiliation:
1. Odessa National Medical University 2. Center of Reconstructive and Restorative Medicine (University Clinic) of Odessa National Medical University
Abstract
Colorectal cancer (CRC) is one of the most common malignancies. Susceptibility to malignant processes is mediated by genetically driven differences in the effectiveness of detoxification of potential carcinogens. One of the factors that may influence the risk of CRC is the glutathione-S-transferase (GST) gene family that encodes glutathione transferase enzymes. The GSTP1 gene is expressed both in normal and pathological conditions. Determining its specific alleles may be a marker of CRC.
The aim of the research – to study GSTP1 gene polymorphism, which is likely to be more common among patients with primary metastatic colorectal cancer compared with healthy population.
Materials and methods. The study involved 12 patients with primary metastatic colorectal cancer aged 43 to 72 years, the control group was represented by a sample of 31 people without cancer.
Results. The incidence of advanced CRC in the presence of GSPT1 Val / Val (aa) polymorphism is statistically significantly higher than in the presence of Ile / Ile (AA) and Ile / Val (Aa) GSPT1 polymorphism.
Conclusions. Among people with GSTP1 Val / Val (aa) polymorphism, primary CRC is 4.4 times more likely than among people with GSPT1 Ile / Ile (AA) and Ile / Val (Aa) polymorphisms, which are statistically significant (P < 0.05). The obtained results indicate the possibility of conducting a genetic study of GSTP1 polymorphism to form groups of potential risk of CRC.
Publisher
OU Scientific Route
Reference20 articles.
1. Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C. et al. (2018). GLOBOCAN 2018 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon: International Agency for Research on Cancer. 2. Van Cutsem, E., Cervantes, A., Nordlinger, B., Arnold, D. (2014). Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 25, 1–9. doi: http://doi.org/10.1093/annonc/mdu260 3. Fedorenko, Z. P., Goulak, L. O., Gorokh, Y. L., Ryzhov, A. Y., Soumkina, E. V., Koutsenko, L. B. (2018). Cancer in Ukraine. Available at: www.ncru.inf.ua/publications/ Last accessed: 21.08.2017 4. Siegel, R. L., Miller, K. D., Jemal, A. (2019). Cancer statistics, 2019. CA: A Cancer Journal for Clinicians, 69 (1), 7–34. doi: http://doi.org/10.3322/caac.21551 5. Cronin, K. A., Lake, A. J., Scott, S., Sherman, R. L., Noone, A.-M., Howlader, N. et. al. (2018). Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics. Cancer, 124 (13), 2785–2800. doi: http://doi.org/10.1002/cncr.31551
|
|